Great Lakes study finds PKD parasite in stocked Pacific salmon
Bottom line
Researchers at Michigan State University and collaborators report the first evidence that Tetracapsuloides bryosalmonae is infecting enhanced migratory Pacific salmon populations in the Great Lakes watershed, including Chinook and coho salmon used in regional stocking programs. The parasite is the cause of proliferative kidney disease, or PKD, a serious salmonid disease better documented in Europe and western North America. In the Great Lakes fish sampled so far, the team found molecular evidence of infection, but not the classic kidney lesions or overt PKD seen in more severely affected populations. The finding adds the Great Lakes to the parasite’s known range and suggests the organism may already be established more broadly in the region than many fish health programs assumed. (units.fisheries.org)
Why it matters: For veterinary and fish health professionals, this is less about an immediate clinical outbreak and more about surveillance, movement risk, and environmental change. T. bryosalmonae is already treated as a priority fish health concern in the Great Lakes, and Michigan lists it as a reportable animal disease. The parasite’s life cycle depends on both salmonids and freshwater bryozoans, and warmer water is associated with higher parasite proliferation and more severe PKD in susceptible fish. That means hatchery, stocking, and wild fish monitoring programs may need to think beyond simple presence/absence testing and pay closer attention to season, water temperature, host species, and subclinical infections. (cvm.msu.edu)
What to watch: Watch for follow-up surveillance on bryozoan hosts, strain characterization, and whether warming Great Lakes tributaries are linked to clinical PKD or expanded detections in additional salmonid populations. (urca.msu.edu)
Key facts
- Pathogen
- Tetracapsuloides bryosalmonae
- Disease
- Proliferative kidney disease (PKD)
- Species involved
- Chinook and coho salmon
- Region
- Great Lakes watershed
- Finding
- Molecular evidence of infection, but no classic kidney lesions or overt PKD in sampled fish
- Clinical status so far
- Infected fish have generally been asymptomatic and carried low parasite burdens
- Regulatory status
- Michigan lists it as a reportable animal disease
- Risk factor
- Warmer water is associated with higher parasite proliferation and more severe PKD
A new report in Animals adds an important disease-surveillance signal for Great Lakes fisheries: researchers say Tetracapsuloides bryosalmonae, the parasite that causes proliferative kidney disease, is infecting enhanced migratory Pacific salmon populations in the region. The work centers on Chinook and coho salmon tied to Great Lakes stocking programs, and it appears to be among the clearest published evidence yet that this pathogen is present in these managed salmon populations in the watershed. (units.fisheries.org)
That matters because PKD is not a new disease globally, but it is a newer concern in the Great Lakes context. T. bryosalmonae has long been recognized as a major pathogen of salmonids in Europe and parts of North America, where it can cause chronic kidney enlargement, anemia, darkened skin, exophthalmia, and significant mortality, particularly when water temperatures rise above about 15 °C. Reviews of the parasite’s ecology have repeatedly linked warmer conditions to greater parasite proliferation and more severe disease expression, raising concerns that climate change could widen its footprint and clinical impact. (mdpi.com)
In the Great Lakes, the picture has been building for several years. A conference abstract from the same research group previously described the discovery of T. bryosalmonae in Great Lakes salmon, and a recent Michigan State University report said the team has now found evidence of the parasite in at least three Great Lakes and several regional rivers. A separate grant summary tied to the project says investigators detected the parasite in adult and juvenile salmonids across multiple states, including first documented detections in several Great Lakes tributaries, Lake Huron salmonids, and both rainbow trout and bryozoans within the same Indiana watershed, which is important because bryozoans are the invertebrate host required for the parasite’s life cycle. (units.fisheries.org)
So far, though, the Great Lakes detections appear to be more epidemiologically important than clinically dramatic. Michigan State’s fish health team has said infected fish in the region have generally been asymptomatic and carried low parasite burdens, and a 2025 European fish pathology meeting abstract from the group similarly noted that PKD has not yet been observed in infected Great Lakes fish. That lines up with remarks captured in Michigan state fisheries meeting minutes, where officials said the parasite had been found in Lake Huron waters, returning adult salmon in Lake Michigan, and steelhead broodstock in neighboring states, but was not causing mortality or visible PKD at that time. (eafp2025.org)
Industry and institutional reaction has been cautious rather than alarmist. Michigan State describes T. bryosalmonae as an emergency fish pathogen for the Great Lakes Fishery Commission and notes that it is on Michigan’s reportable animal disease list. The Great Lakes Fishery Commission’s 2025 fish health priorities also flag T. bryosalmonae as a research need, underscoring that agencies see unanswered questions around distribution, host susceptibility, and management significance. In other words, the detection itself is no longer the only story; the bigger issue is whether the region is looking at a low-pathogenicity local pattern, a strain-specific phenomenon, or an early warning sign ahead of broader disease emergence. That last point is an inference based on current surveillance gaps and the contrast between parasite presence and limited clinical disease to date. (cvm.msu.edu)
Why it matters: For veterinary professionals working in aquatic animal health, this finding reinforces the need to treat subclinical detections seriously, especially in systems shaped by stocking, fish movement, and warming freshwater habitats. If T. bryosalmonae is established in Great Lakes salmonids and bryozoans, health programs may need more targeted seasonal sampling, stronger integration of histopathology with molecular testing, and closer coordination between hatcheries, wildlife agencies, and diagnostic labs. It also raises practical questions about which host species are acting as reservoirs, whether Pacific salmon in the Great Lakes are dead-end hosts or contributors to transmission, and how often clinically silent infections could complicate broodstock management or mask risk in mixed wild and enhanced populations. (fishwildlife.org)
What to watch: The next steps are likely to be broader surveillance, more work on parasite genetics and host range, and closer tracking of summer water temperatures in tributaries where salmonids and bryozoans overlap. If future studies confirm lifecycle completion in the watershed, identify more susceptible species or strains, or link hotter seasons with histologic kidney disease, this could shift from an interesting surveillance finding to a more operational veterinary and fisheries management issue. (urca.msu.edu)
Common questions
Which fish are affected?
The article names enhanced migratory Chinook and coho salmon in Great Lakes stocking programs.What signs of disease were found?
Researchers found molecular evidence of infection, but not the classic kidney lesions or overt PKD seen in more severely affected populations.Is this causing illness or deaths in Great Lakes fish?
So far, the article says infected fish have generally been asymptomatic, carried low parasite burdens, and had not shown PKD or mortality at the time described.Why does this matter for fish health programs?
The article says the finding raises surveillance, movement risk, and environmental change concerns, especially because warmer water is linked to greater parasite proliferation and more severe disease.